Title:

Anti-inflammatory effect of chamomile from randomized clinical trials: a systematic review and meta-analyses

 

Objective:

To explore chamomile as a low-risk antimicrobial and anti-inflammatory agent, utilizing clinical characteristics derived from the existing body of evidence from randomized clinical trials within the current literature.

 

Results:

Statistical tests from the meta-analysis demonstrated that chamomile exhibited statistically significant reductions in mucositis severity and pain level, indicating the anti-inflammatory effects of chamomile.

 

Conclusion:

Chamomile demonstrates anti-inflammatory effects, evidenced by reductions in mucositis severity and pain across randomised controlled trials. These findings support its potential as a low-risk adjunctive agent for managing inflammation-related gastrointestinal and mucosal conditions.

 

Full study link can be found HERE.